Decarboxylative borylation

Science

Volumn 356, Issue 6342, 2017, Pages

  Li, Chao ^a   Wang, Jie ^a   Barton, Lisa M ^a   Yu, Shan ^b   Tian, Maoqun ^a   Peters, David S ^a   Kumar, Manoj ^b   Yu, Antony W ^a   Johnson, Kristen A ^b   Chatterjee, Arnab K ^b   Yan, Ming ^a   Baran, Phil S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Calibr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; BORONIC ACID DERIVATIVE; BORTEZOMIB; CARBOXYLIC ACID; ESTER DERIVATIVE; IXAZOMIB; LEUKOCYTE ELASTASE INHIBITOR; NICKEL; PEPTIDE; VANCOMYCIN; BORON; DRUG;

AMINO ACID; ANTIBIOTICS; CARBOXYLIC ACID; CATALYSIS; CHEMICAL BINDING; DECARBOXYLATION; DRUG; INHIBITOR; PEPTIDE;

ARTICLE; BORYLATION; CATALYSIS; CHEMICAL REACTION; COVALENT BOND; DECARBOXYLATION; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOSELECTIVITY;

BORON; BORONIC ACIDS; CARBOXYLIC ACIDS; PHARMACEUTICAL PREPARATIONS;

EID: 85017660132     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aam7355     Document Type: Article

References (55)

1. A. Suzuki, Cross-coupling reactions of organoboranes: An easy way to construct C-C bonds (Nobel Lecture). Angew. Chem. Int. Ed. 50, 6722-6737 (2011). doi: 10.1002/ anie.201101379; pmid: 21618370
2. W. L. A. Brooks, B. S. Sumerlin, Synthesis and applications of boronic acid-containing polymers: From materials to medicine. Chem. Rev. 116, 1375-1397 (2016). doi: 10.1021/acs.chemrev.5b00300; pmid: 26367140
3. S. D. Bull et al., Exploiting the reversible covalent bonding of boronic acids: Recognition, sensing, and assembly. Acc. Chem. Res. 46, 312-326 (2013). doi: 10.1021/ar300130w; pmid: 23148559
4. P. C. Trippier, C. McGuigan, Boronic acids in medicinal chemistry: Anticancer, antibacterial and antiviral applications. MedChemComm 1, 183 (2010). doi: 10.1039/ c0md00119h
5. A. Draganov, D. Wang, B. Wang, The future of boron in medicinal chemistry: Therapeutic and diagnostic applications. In Atypical Elements in Drug Design, J. Schwarz, Ed. (Springer, 2014), pp. 1-27. doi: 10.1007/7355-2014-65
6. C. Ballatore, D. M. Huryn, A. B. Smith 3rd, Carboxylic acid (bio) isosteres in drug design. ChemMedChem 8, 385-395 (2013). doi: 10.1002/cmdc.201200585; pmid: 23361977
7. R. Smoum, A. Rubinstein, V. M. Dembitsky, M. Srebnik, Boron containing compounds as protease inhibitors. Chem. Rev. 112, 4156-4220 (2012). doi: 10.1021/cr608202m; pmid: 22519511
8. H. C. Brown, Hydroboration (Benjamin/Cummings, 1980).
9. C. M. Vogels, S. A. Westcott, Recent advances in organic synthesis using transition metal-catalyzed hydroborations. Curr. Org. Chem. 9, 687-699 (2005). doi: 10.2174/ 1385272053765060
10. A. S. Dudnik, G. C. Fu, Nickel-catalyzed coupling reactions of alkyl electrophiles, including unactivated tertiary halides, to generate carbon-boron bonds. J. Am. Chem. Soc. 134, 10693-10697 (2012). doi: 10.1021/ja304068t; pmid: 22668072
11. T. C. Atack, R. M. Lecker, S. P. Cook, Iron-catalyzed borylation of alkyl electrophiles. J. Am. Chem. Soc. 136, 9521-9523 (2014). doi: 10.1021/ja505199u; pmid: 24955892
12. R. B. Bedford et al., Iron-catalyzed borylation of alkyl, allyl, and aryl halides: Isolation of an iron(I) boryl complex. Organometallics 33, 5940-5943 (2014). doi: 10.1021/ om500847j
13. C.-T. Yang et al., Alkylboronic esters from copper-catalyzed borylation of primary and secondary alkyl halides and pseudohalides. Angew. Chem. Int. Ed. 51, 528-532 (2012). doi: 10.1002/anie.201106299; pmid: 22135233
14. H. Ito, K. Kubota, Copper(I)-catalyzed boryl substitution of unactivated alkyl halides. Org. Lett. 14, 890-893 (2012). doi: 10.1021/ol203413w; pmid: 22260229
15. H. C. Brown, T. E. Cole, Organoboranes.
16. A simple preparation of boronic esters from organolithium reagents and selected trialkoxyboranes. Organometallics 2, 1316-1319 (1983). doi: 10.1021/om50004a009
17. K. S. Lee, A. R. Zhugralin, A. H. Hoveyda, Efficient C-B bond formation promoted by N-heterocyclic carbenes: Synthesis of tertiary and quaternary B-substituted carbons through metal-free catalytic boron conjugate additions to cyclic and acyclic a,b-unsaturated carbonyls. J. Am. Chem. Soc. 131, 7253-7255 (2009). doi: 10.1021/ja902889s; pmid: 19432440
18. J. A. Schiffner, K. M?ther, M. Oestreich, Enantioselective conjugate borylation. Angew. Chem. Int. Ed. 49, 1194-1196 (2010). doi: 10.1002/anie.200906521; pmid: 20077553
19. P. Andrés, G. Ballano, M. I. Calaza, C. Cativiela, Synthesis of a-aminoboronic acids. Chem. Soc. Rev. 45, 2291-2307 (2016). doi: 10.1039/C5CS00886G; pmid: 26853637
20. M. A. Beenen, C. An, J. A. Ellman, Asymmetric coppercatalyzed synthesis of a-amino boronate esters from N-tertbutanesulfinyl aldimines. J. Am. Chem. Soc. 130, 6910-6911 (2008). doi: 10.1021/ja800829y; pmid: 18461938
21. I. A. Mkhalid, J. H. Barnard, T. B. Marder, J. M. Murphy, J. F. Hartwig, C-H activation for the construction of C-B bonds. Chem. Rev. 110, 890-931 (2010). doi: 10.1021/cr900206p; pmid: 20028025
22. E. J. Olhava, M. D. Danca, U.S. patent 7442830 (2008).
23. T. Qin et al., A general alkyl-alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents. Science 352, 801-805 (2016). doi: 10.1126/science.aaf6123; pmid: 27103669
24. J. Cornella et al., Practical Ni-catalyzed aryl-alkyl cross-coupling of secondary redox-active esters. J. Am. Chem. Soc. 138, 2174-2177 (2016). doi: 10.1021/jacs.6b00250; pmid: 26835704
25. J. Wang et al., Nickel-catalyzed cross-coupling of redox-active esters with boronic acids. Angew. Chem. Int. Ed. 55, 9676-9679 (2016). doi: 10.1002/anie.201605463; pmid: 27380912
26. F. Toriyama et al., Redox-active esters in Fe-catalyzed C-C coupling. J. Am. Chem. Soc. 138, 11132-11135 (2016). doi: 10.1021/jacs.6b07172; pmid: 27548696
27. T. Qin et al., Nickel-catalyzed barton decarboxylation and Giese reactions: A practical take on classic transforms. Angew. Chem. Int. Ed. 56, 260-265 (2017). doi: 10.1002/ anie.201609662; pmid: 27981703
28. T. Hatakeyama et al., Iron-catalyzed Suzuki-Miyaura coupling of alkyl halides. J. Am. Chem. Soc. 132, 10674-10676 (2010). doi: 10.1021/ja103973a; pmid: 20681696
29. R. B. Bedford et al., Expedient iron-catalyzed coupling of alkyl, benzyl and allyl halides with arylboronic esters. Chemistry 20, 7935-7938 (2014). doi: 10.1002/chem.201402174; pmid: 24715587
30. R. Al Hussainy et al., Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor. J. Med. Chem. 54, 3480-3491 (2011). doi: 10.1021/jm1009956; pmid: 21520940
31. P. Lassalas et al., Structure property relationships of carboxylic acid isosteres. J. Med. Chem. 59, 3183-3203 (2016). doi: 10.1021/acs.jmedchem.5b01963; pmid: 26967507
32. J. Schmidt, J. Choi, A. T. Liu, M. Slusarczyk, G. C. Fu, A general, modular method for the catalytic asymmetric synthesis of alkylboronate esters. Science 354, 1265-1269 (2016). doi: 10.1126/science.aai8611; pmid: 27940868
33. Y. Xi, J. F. Hartwig, Diverse asymmetric hydrofunctionalization of aliphatic internal alkenes through catalytic regioselective hydroboration. J. Am. Chem. Soc. 138, 6703-6706 (2016). doi: 10.1021/jacs.6b02478;pmid: 27167490
34. G. A. Molander, N. Ellis, Organotrifluoroborates: Protected boronic acids that expand the versatility of the Suzuki coupling reaction. Acc. Chem. Res. 40, 275-286 (2007). doi: 10.1021/ ar050199q; pmid: 17256882
35. S. N. Mlynarski, A. S. Karns, J. P. Morken, Direct stereospecific amination of alkyl and aryl pinacol boronates. J. Am. Chem. Soc. 134, 16449-16451 (2012). doi: 10.1021/ja305448w; pmid: 23002712
36. A. Bonet, M. Odachowski, D. Leonori, S. Essafi, V. K. Aggarwal, Enantiospecific sp2-sp3 coupling of secondary and tertiary boronic esters. Nat. Chem. 6, 584-589 (2014). doi: 10.1038/ nchem.1971; pmid: 24950327
37. S. Laulhé, J. M. Blackburn, J. L. Roizen, Selective and serial Suzuki-Miyaura reactions of polychlorinated aromatics with alkyl pinacol boronic esters. Org. Lett. 18, 4440-4443 (2016). doi: 10.1021/acs.orglett.6b02323; pmid: 27537216
38. V. M. Dembitsky, M. Srebnik, Synthesis and biological activity of a-aminoboronic acids, amine-carboxyboranes and their derivatives. Tetrahedron 59, 579-593 (2003). doi: 10.1016/ S0040-4020(02)01618-6
39. J. J. McAtee, S. L. Castle, Q. Jin, D. L. Boger, Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine. Bioorg. Med. Chem. Lett. 12, 1319-1322 (2002). doi: 10.1016/S0960-894X(02)00130-0; pmid: 11965380
40. F. J. Brown et al., Design of orally active, non-peptidic inhibitors of human leukocyte elastase. J. Med. Chem. 37, 1259-1261 (1994). doi: 10.1021/jm00035a004; pmid: 8176703
41. C. A. Veale et al., Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase. J. Med. Chem. 40, 3173-3181 (1997). doi: 10.1021/jm970250z; pmid: 9379436
42. P. R. Bernstein, B. C. Gomes, B. J. Kosmider, E. P. Vacek, J. C. Williams, Nonpeptidic inhibitors of human leukocyte elastase. 6. Design of a potent, intratracheally active, pyridone-based trifluoromethyl ketone. J. Med. Chem. 38, 212-215 (1995). doi: 10.1021/jm00001a028; pmid: 7837235
43. J. P. Burkhart et al., Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug. J. Med. Chem. 38, 223-233 (1995). doi: 10.1021/jm00002a003; pmid: 7830264
44. P. D. Edwards et al., Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase. J. Med. Chem. 40, 1876-1885 (1997). doi: 10.1021/jm960819g; pmid: 9191965
45. K. Hemmi, I. Shima, K. Imai, H. Tanaka, European patent EP0494071 (1992).
46. T. Kinoshita, I. Nakanishi, A. Sato, T. Tada, True interaction mode of porcine pancreatic elastase with FR136706, a potent peptidyl inhibitor. Bioorg. Med. Chem. Lett. 13, 21-24 (2003). doi: 10.1016/S0960-894X(02)00852-1; pmid: 12467609
47. F. von Nussbaum, V. M.-J. Li, Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores. Bioorg. Med. Chem. Lett. 25, 4370-4381 (2015). doi: 10.1016/j.bmcl.2015.08.049; pmid: 26358162
48. F. von Nussbaum et al., Freezing the bioactive conformation to boost potency: The identification of BAY 85-8501, a selective and potent inhibitor of human neutrophil elastase for pulmonary diseases. ChemMedChem 10, 1163-1173 (2015). doi: 10.1002/cmdc.201500131; pmid: 26083237
49. F. O. Gombert et al., patent application WO2015096873 (2015).
50. T. J. Blench et al., patent application WO2013037809 (2013).
51. L. Bergström, M. Lundkvist, H. Lönn, P. Sjö, patent application WO2008030158 (2008).
52. M. D. Shultz, The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations. Bioorg. Med. Chem. Lett. 23, 5992-6000 (2013). doi: 10.1016/j.bmcl.2013.08.030; pmid: 24054120
53. A. Zervosen et al., Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein. J. Am. Chem. Soc. 133, 10839-10848 (2011). doi: 10.1021/ja200696y; pmid: 21574608
54. M. Groll, C. R. Berkers, H. L. Ploegh, H. Ovaa, Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. Structure 14, 451-456 (2006). doi: 10.1016/j.str.2005.11.019; pmid: 16531229
55. A. F. Kisselev, W. A. van der Linden, H. S. Overkleeft, Proteasome inhibitors: An expanding army attacking a unique target. Chem. Biol. 19, 99-115 (2012). doi: 10.1016/ j.chembiol.2012.01.003; pmid: 22284358